D-0445-2024 Class II

Recalled by Eli Lilly & Company — Indianapolis, IN

Recall Details

Product Type
Drugs
Report Date
April 24, 2024
Initiation Date
March 12, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
700 vials

Product Description

Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285. NDC: 0002-0800-01

Reason for Recall

CGMP Deviations

Distribution Pattern

Nationwide USA

Code Information

Batch number: D608951C, exp 4/10/2025